Dr. Chan specializes in the surgical and medical treatment of ovarian and other
pelvic cancers at CPMC. He is board certified in gynecologic oncology, and obstetrics
and gynecology. He is investigating new treatments for gynecologic cancers,
including targeted biologic therapies, and exploring the role of tumor-initiating
cells in ovarian cancer. A clinician and surgeon, Dr. Chan is a principal investigator
of studies assessing the treatment and health outcomes of ovarian and uterine cancer
patients.
California Pacific Medical Center Research Institute
1501 Trousdale Drive
Burlingame, CA, 94010
(415) 751-1847
ChanJK@Sutterhealth.org
Primary Research Interests
Related Clinical Trials
Locally Advanced or Metastatic (Roche YO40482)
Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab
to Patients With Advanced Platinum-sensitive Ovarian Cancer
Investigators: John Chung-Kai Chan M.D., Lejla Delic MD
Locally Advanced or Metastatic (Syros SY 1365-101)
A Phase 1 Study of SY-1365, a Selective CDK7 Inhibitor, in Adult Patients with Advanced
Solid Tumors
Investigators: John Chung-Kai Chan M.D., Lejla Delic MD